Palmar-plantar erythrodysaesthesia and non-pegylated liposomal doxorubicin. A case study.
作者信息
Tamayo-Orbegozo E, Iruin-Sanz A, Oñate-Muzás E, Segrelles-Bellmunt G
出版信息
Farm Hosp. 2011 Jan-Feb;35(1):46-7. doi: 10.1016/j.farma.2010.03.002. Epub 2010 Jul 8.
PMID:20619714
Abstract
摘要
相似文献
1
Palmar-plantar erythrodysaesthesia and non-pegylated liposomal doxorubicin. A case study.
Farm Hosp. 2011 Jan-Feb;35(1):46-7. doi: 10.1016/j.farma.2010.03.002. Epub 2010 Jul 8.
2
Incidence of palmar-plantar erythrodysesthesia in pretreated and unpretreated patients receiving pegylated liposomal doxorubicin.
Tumori. 2009 Nov-Dec;95(6):687-90. doi: 10.1177/030089160909500608.
3
Pyridoxine as prophylactic therapy for palmar-plantar erythrodysesthesia associated with administration of pegylated liposomal doxorubicin (caelyx): a single-center experience.
Oncology. 2007;73(3-4):277-8. doi: 10.1159/000127427. Epub 2008 Apr 17.
4
[Liposomal doxorubicin and palmoplantar erythrodysesthesia].
Ann Dermatol Venereol. 2003 Nov;130(11):1057-8.
5
Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer.
Gynecol Oncol. 2009 Aug;114(2):219-24. doi: 10.1016/j.ygyno.2009.04.007. Epub 2009 May 17.
6
Elevated body mass index does not increase the risk of palmar-plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin.
Gynecol Oncol. 2006 Oct;103(1):72-4. doi: 10.1016/j.ygyno.2006.01.031. Epub 2006 Feb 21.
7
Anthracycline-induced toxicity affecting palmar and plantar skin.
Br J Cancer. 1989 May;59(5):814. doi: 10.1038/bjc.1989.170.
8
The effect of regional cooling on toxicity associated with intravenous infusion of pegylated liposomal doxorubicin in recurrent ovarian carcinoma.
Gynecol Oncol. 2004 May;93(2):513-6. doi: 10.1016/j.ygyno.2004.02.019.
9
"Skin problems associated with pegylated liposomal doxorubicin -- more than palmoplantar erythrodysesthesia syndrome".
Eur J Dermatol. 2009 May-Jun;19(3):264-5. doi: 10.1684/ejd.2009.0630. Epub 2009 Feb 12.
10
[Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
Ugeskr Laeger. 2003 Aug 11;165(33):3161-2.
Zotero 插件